| ABIO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ABIO shares outstanding history going back to 9/4/2015:
Also see: ABIO Market Cap History ABIO YTD Return |
ABIO Shares Outstanding History — ARCA biopharma Share Count Over Time
As of 7/31/2024 ARCA biopharma has 14.51 million ABIO shares outstanding. Investors often track the ABIO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ABIO share count trends over time, with 36 historical shares outstanding datapoints presented, dating back to 9/4/2015.
| ABIO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABIO Historical Shares Outstanding: +45.86% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABIO Stock Price Chart |
| About Oruka Therapeutics Inc |
| ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. We show 36 historical shares outstanding datapoints in our coverage of ABIO's shares outstanding history. Understanding the changing numbers of ABIO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABIO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABIO by allowing them to research ABIO shares outstanding history as well as any other stock in our coverage universe. |
| ABIO Current Stock Quote |
Quotes delayed 20 minutes  Free ABIO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ABIO Share Performance |
| Shares Outstanding Peers |
| ARCA biopharma (ABIO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ABMD Shares Outstanding History ABOS Shares Outstanding History ABSI Shares Outstanding History ABT Shares Outstanding History ABVC Shares Outstanding History ACAD Shares Outstanding History ACCD Shares Outstanding History ACER Shares Outstanding History ACET Shares Outstanding History ACGN Shares Outstanding History More Healthcare companies » |
ABIO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
